Former NIH director Monica Bertagnolli and other scientists discussed the impact of reduced funding on cancer research and ...

Non-coding RNAs (ncRNAs), once considered the 'dark matter' of the genome, have now emerged as pivotal regulators in cancer ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

(THE CONVERSATION) Cancer research in the U.S. doesn’t rely on a single institution or funding stream − it’s a complex ecosystem made up of interdependent parts: academia, pharmaceutical companies, ...

Champions Oncology, Inc.’s CSBR share price has surged by 8.58%, which has investors questioning if this is right time to ...